Sulfite Impairs Bioenergetics and Redox Status in Neonatal Rat Brain: Insights into the Early Neuropathophysiology of Isolated Sulfite Oxidase and Molybdenum Cofactor Deficiencies

[1]  G. Leipnitz,et al.  Neuronal Death, Glial Reactivity, Microglia Activation, Oxidative Stress and Bioenergetics Impairment Caused by Intracerebroventricular Administration of D-2-hydroxyglutaric Acid to Neonatal Rats , 2021, Neuroscience.

[2]  F. Guma,et al.  Ethylmalonic acid impairs bioenergetics by disturbing succinate and glutamate oxidation and induces mitochondrial permeability transition pore opening in rat cerebellum , 2021, Journal of neurochemistry.

[3]  C. Gonçalves,et al.  Ammonia-Induced Glial-Inflammaging , 2020, Molecular Neurobiology.

[4]  Ying Xu,et al.  ERK/MAPK signalling pathway and tumorigenesis , 2020, Experimental and therapeutic medicine.

[5]  A. Saini,et al.  Metabolic crisis after trivial head trauma in late-onset isolated sulfite oxidase deficiency: Report of two new cases and review of published patients , 2019, Brain and Development.

[6]  A. Kowaltowski,et al.  Neurological disorders and mitochondria. , 2020, Molecular aspects of medicine.

[7]  P. Wipf,et al.  ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts , 2019, Scientific Reports.

[8]  Renfu Quan,et al.  The Mechanism of MAPK Signal Transduction Pathway Involved with Electroacupuncture Treatment for Different Diseases , 2019, Evidence-based complementary and alternative medicine : eCAM.

[9]  G. Leipnitz,et al.  Bezafibrate In Vivo Administration Prevents 3-Methylglutaric Acid-Induced Impairment of Redox Status, Mitochondrial Biogenesis, and Neural Injury in Brain of Developing Rats , 2019, Neurotoxicity Research.

[10]  G. Leipnitz,et al.  The Role of Oxidative Stress and Bioenergetic Dysfunction in Sulfite Oxidase Deficiency: Insights from Animal Models , 2018, Neurotoxicity Research.

[11]  A. Szegedi,et al.  Heme Oxygenase and the Skin in Health and Disease. , 2018, Current pharmaceutical design.

[12]  V. Vijayan,et al.  The macrophage heme-heme oxygenase-1 system and its role in inflammation. , 2018, Biochemical pharmacology.

[13]  Bora Özbakır,et al.  Molybdenum cofactor deficiency: Neuroimaging findings , 2018, Radiology case reports.

[14]  M. Cilio,et al.  Neonatal epilepsies: Clinical management. , 2018, Seminars in fetal & neonatal medicine.

[15]  K. Jansen,et al.  Isolated sulfite oxidase deficiency , 2018, Journal of Inherited Metabolic Disease.

[16]  G. Leipnitz,et al.  Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[17]  Hsiu-Fen Lee,et al.  Prenatal brain disruption in isolated sulfite oxidase deficiency , 2017, Orphanet Journal of Rare Diseases.

[18]  G. Leipnitz,et al.  Disruption of Energy Transfer and Redox Status by Sulfite in Hippocampus, Striatum, and Cerebellum of Developing Rats , 2017, Neurotoxicity Research.

[19]  Jian-Guo Chen,et al.  Sulfite triggers sustained calcium overload in cultured cortical neurons via a redox-dependent mechanism. , 2016, Toxicology letters.

[20]  J. Gleeson,et al.  Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[21]  G. Schwarz.  Molybdenum cofactor and human disease. , 2016, Current opinion in chemical biology.

[22]  G. Nan,et al.  The Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway as a Discovery Target in Stroke , 2016, Journal of Molecular Neuroscience.

[23]  T. Wai,et al.  Mitochondrial Dynamics and Metabolic Regulation , 2016, Trends in Endocrinology & Metabolism.

[24]  F. Scaglia,et al.  Molybdenum cofactor deficiency , 2018, Atlas of Inherited Metabolic Diseases.

[25]  J. Zweier,et al.  Sulfite oxidase activity of cytochrome c: Role of hydrogen peroxide , 2015, Biochemistry and Biophysics Reports.

[26]  T. Kietzmann,et al.  Antioxidant responses and cellular adjustments to oxidative stress , 2015, Redox biology.

[27]  G. Leipnitz,et al.  In vitro evidence that sulfite impairs glutamatergic neurotransmission and inhibits glutathione metabolism-related enzymes in rat cerebral cortex , 2015, International Journal of Developmental Neuroscience.

[28]  E. Choi,et al.  Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.

[29]  G. Leipnitz,et al.  Sulfite disrupts brain mitochondrial energy homeostasis and induces mitochondrial permeability transition pore opening via thiol group modification. , 2014, Biochimica et biophysica acta.

[30]  W. Reese,et al.  Infantile spasms and hyperekplexia associated with isolated sulfite oxidase deficiency. , 2014, JAMA neurology.

[31]  L. Meylaerts,et al.  Sulfite oxidase deficiency in a newborn. , 2014, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[32]  A. I. Dias,et al.  Sulfite oxidase deficiency – An unusual late and mild presentation , 2014, Brain and Development.

[33]  H. Hirt,et al.  The role of ABA and MAPK signaling pathways in plant abiotic stress responses. , 2014, Biotechnology advances.

[34]  L. Barbeito,et al.  White Matter Injury Induced by Perinatal Exposure to Glutaric Acid , 2014, Neurotoxicity Research.

[35]  G. Leipnitz,et al.  Disturbance of brain energy and redox homeostasis provoked by sulfite and thiosulfate: potential pathomechanisms involved in the neuropathology of sulfite oxidase deficiency. , 2013, Gene.

[36]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[37]  G. Schwarz,et al.  Cofactor-dependent maturation of mammalian sulfite oxidase links two mitochondrial import pathways , 2012, Journal of Cell Science.

[38]  V. Kuçukatay,et al.  Sulfite leads to neuron loss in the hippocampus of both normal and SOX-deficient rats , 2012, Neurochemistry International.

[39]  P. Waters,et al.  Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency , 2012, Journal of Inherited Metabolic Disease.

[40]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[41]  Daeui Park,et al.  Hydrogen peroxide targets the cysteine at the active site and irreversibly inactivates creatine kinase. , 2011, International journal of biological macromolecules.

[42]  L. Barbeito,et al.  Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I , 2011, PloS one.

[43]  H. Mandel,et al.  Prenatal Brain Disruption in Molybdenum Cofactor Deficiency , 2011, Journal of child neurology.

[44]  J. Reiss,et al.  Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2 , 2011, Human mutation.

[45]  A. Gunduz,et al.  Functional deficiencies of sulfite oxidase: Differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia , 2010, Brain and Development.

[46]  F. Wong,et al.  Successful Treatment of Molybdenum Cofactor Deficiency Type A With cPMP , 2010, Pediatrics.

[47]  L. J. Eldik,et al.  Targeting protein kinases in central nervous system disorders , 2009, Nature Reviews Drug Discovery.

[48]  Hongqiao Zhang,et al.  Glutathione: overview of its protective roles, measurement, and biosynthesis. , 2009, Molecular aspects of medicine.

[49]  P. O'Brien,et al.  Mechanism of sulfite cytotoxicity in isolated rat hepatocytes. , 2008, Chemico-biological interactions.

[50]  A. Wyse,et al.  Sulfite increases lipoperoxidation and decreases the activity of catalase in brain of rats , 2008, Metabolic Brain Disease.

[51]  T. Kushnir,et al.  Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Isolated Sulfite Oxidase Deficiency , 2007, Journal of child neurology.

[52]  K. Poskitt,et al.  Isolated sulfite oxidase deficiency in the newborn: lactic acidaemia and leukoencephalopathy. , 2007, Neuropediatrics.

[53]  F. Eichler,et al.  Isolated Sulfite Oxidase Deficiency: A Case Report With a Novel Mutation and Review of the Literature , 2005, Pediatrics.

[54]  A. Agar,et al.  Effect of sulfite on macrophage functions of normal and sulfite oxidase-deficient rats. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[55]  T. Coşkun,et al.  Molybdenum Cofactor Deficiency Presenting With Severe Metabolic Acidosis and Intracranial Hemorrhage , 2005, Journal of child neurology.

[56]  Jesus Avila,et al.  Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.

[57]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[58]  Jean L. Johnson.  Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency , 2003, Prenatal diagnosis.

[59]  D. Ramsay,et al.  Isolated sulfite oxidase deficiency. , 1996, Neuropediatrics.

[60]  T. Bourgeron,et al.  Biochemical and molecular investigations in respiratory chain deficiencies. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[61]  S. Tsuchida,et al.  Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide. , 1993, Archives of biochemistry and biophysics.

[62]  J. Berden,et al.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[63]  S. Leong,et al.  Regional enzyme development in rat brain. Enzymes associated with glucose utilization. , 1984, The Biochemical journal.

[64]  B. P. Hughes.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. , 1962, Clinica chimica acta; international journal of clinical chemistry.